Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
AstraZeneca
McKesson
Express Scripts
Medtronic

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for L-Citrulline

See Plans and Pricing

« Back to Dashboard

What is the drug development status for L-Citrulline?

L-Citrulline is an investigational drug.

There have been 18 clinical trials for L-Citrulline. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2006.

The most common disease conditions in clinical trials are Bronchopulmonary Dysplasia, Syndrome, and Anemia, Sickle Cell. The leading clinical trial sponsors are Asklepion Pharmaceuticals, LLC, Angiogenix, and University Hospital, Basel, Switzerland.

Recent Clinical Trials for L-Citrulline
TitleSponsorPhase
Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesNational Heart, Lung, and Blood Institute (NHLBI)Phase 2
Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesNational Institutes of Health (NIH)Phase 2
Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesUniversity of Colorado, DenverPhase 2

See all L-Citrulline clinical trials

Clinical Trial Summary for L-Citrulline

Top disease conditions for L-Citrulline
Top clinical trial sponsors for L-Citrulline

See all L-Citrulline clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKinsey
Baxter
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.